Meeting
2023 ASCO Genitourinary Cancers Symposium
Is pathological upstaging to T3a renal cell carcinoma associated with a similar prognosis to non-upstaged pathologic T3a disease? A multicenter analysis.
Authors
Ryan Nasseri
University of California San Diego, Department of Urology, La Jolla, CA
Ryan Nasseri , Kevin Hakimi , Jonathan Afari , Ava Saidian , Ricardo Autorino , Brian R. Lane , Michele Marchioni , Dattatraya H Patil , Chandru Sundaram , Hajime Tanaka , Francesco Porpiglia , Sabrina L. Noyes , James R Porter , Viraj A. Master , Andrea Minervini , Umberto Capitanio , Francesco Montorsi , Ithaar H Derweesh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 656)
DOI
10.1200/JCO.2023.41.6_suppl.656
Abstract #
656
Poster Bd #
G7
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Preoperative c-reactive protein and risk of major complications and mortality outcomes in patients undergoing surgery for renal cell carcinoma.
First Author: Franklin Liu
Poster
2023 ASCO Genitourinary Cancers Symposium
Creatinine to cystatin C ratio and mortality in renal cell carcinoma.
First Author: Benjamin Schmeusser
Poster
2020 Genitourinary Cancers Symposium
Impact of diabetes mellitus on functional and survival outcomes in renal cell carcinoma: An international multicenter study.
First Author: Raksha Dutt
Poster
2020 Genitourinary Cancers Symposium
Multicenter comparison of outcomes for clinical and pathologic T3a renal cell carcinoma.
First Author: Aaron Bradshaw